Loading…
avatar for Bennett Levitan

Bennett Levitan

Janssen Research & Development, LLC
Senior Director, Benefit-Risk Assessment, Global R&D Epidemiology
Bennett Levitan, MD-PhD is Senior Director, Global R&D Epidemiology at Janssen R&D. He introduced state of the art patient-focused benefit-risk assessment to Janssen and his team has led numerous clinical teams in benefit-risk assessments and patient preference studies. He co-led development of the PhRMA BRAT Framework and the MDIC Patient-Centered Benefit-Risk Framework. He serves on several committees that inform policy on benefit-risk methods including IMI PREFER and PhRMA's Patient-Focused Drug Development Work Group. He received his B.Sc. (Electrical Eng) from Columbia University and his M.D.-Ph.D. (Bioengineering) from the Univ of Pennsylvania.